HAL (France)open access
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
JAK1 inhibitor, Ulcerative colitis, 0, Small molecule, Upadacitinib, Inflammatory bowel disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 624873
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.